🕵️ Braveheart BIO, Inc. ($BRVE)
SEC insider & ownership activity, last 12 months · CIK 2131524 · every row links its SEC filing
Insider buy value was withheld pending verification over the last 12 months. Orbimed Advisors LLC trimmed 17.2% → 13.5%; OrbiMed Capital GP IX LLC trimmed 16.9% → 13.2%. No red-flag 8-Ks in the window.
Insider flow
10 buyers, value withheld pending verification (13 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Orbimed Advisors LLC | 2 | value withheld pending verification | 0 | – | Aug 7, 2026 |
| Chimovits Erez | 2 | value withheld pending verification | 0 | – | Aug 7, 2026 |
| Lubner David Charles | 1 | value withheld pending verification | 0 | – | Aug 7, 2026 |
| Viehbacher Christopher | 1 | value withheld pending verification | 0 | – | Aug 7, 2026 |
| James Paul Rickey | 1 | value withheld pending verification | 0 | – | Aug 7, 2026 |
| Murdoch Travis | 1 | value withheld pending verification | 0 | – | Aug 7, 2026 |
| Michele A. Anderson | 1 | value withheld pending verification | 0 | – | Aug 7, 2026 |
| David I. Malek | 1 | value withheld pending verification | 0 | – | Aug 7, 2026 |
| Forbion Growth Opportunities Fund III Cooperatief U.A. | 2 | value withheld pending verification | 0 | – | Aug 7, 2026 |
| AH BIO Fund IV, L.P. | 1 | value withheld pending verification | 0 | – | Aug 7, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Orbimed Advisors LLC | 13.5% | 13D | Sep 8, 2026 | filing ↗ | |
| OrbiMed Capital GP IX LLC | 13.2% | 13D | Sep 8, 2026 | filing ↗ | |
| Benjamin A. Horowitz | 11.4% | 13D | Aug 7, 2026 | filing ↗ | |
| Marc L. Andreessen | 11.4% | 13D | Aug 7, 2026 | filing ↗ | |
| AH BIO Fund IV, L.P. | 11.4% | 13D | Aug 7, 2026 | filing ↗ | |
| AH Equity Partners BIO IV, L.L.C. | 11.4% | 13D | Aug 7, 2026 | filing ↗ | |
| Frazier Life Sciences Public Fund, L.P. | 5.5% | 13G | Aug 14, 2026 | filing ↗ | |
| Fhmlsp, L.P. | 5.5% | 13G | Aug 14, 2026 | filing ↗ | |
| Fhmlsp, L.L.C. | 5.5% | 13G | Aug 14, 2026 | filing ↗ | |
| OrbiMed Genesis GP LLC | exited | 13D | Sep 8, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Sep 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 8, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Aug 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 5, 2026 | filing ↗ |